MedPath

A study to compare the effectiveness and safety of different doses of a drug clonidine when used along with a drug bupivacaine in spinal anesthesia

Phase 1
Conditions
Health Condition 1: S729- Unspecified fracture of femurHealth Condition 2: S929- Unspecified fracture of foot and toeHealth Condition 3: S829- Unspecified fracture of lower leg
Registration Number
CTRI/2019/05/019341
Lead Sponsor
J J hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I or II normotensive patients undergoing elective orthopaedic surgery

Exclusion Criteria

ASA III & above, patients with cardiovascular, renal, liver dysfunction, allergy to clonidine or bupivacaine, short height ( <130cm), obese(BMI > 30kg/m2) or with contraindication to spinal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesia/sensory block <br/ ><br>Block height <br/ ><br>Hemodynamic variations-pulse, MAP <br/ ><br>ComplicationsTimepoint: 1year
Secondary Outcome Measures
NameTimeMethod
Hemodynamic effects-pulse and MAP <br/ ><br>ComplicationsTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath